Vaccination programs save millions of lives each year globally. With more than 100 million children immunized each year, global immunization coverage has never been higher. Sources indicate that the worldwide market for vaccines is expected to reach USD 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3% from 2016 to 2021. The key drivers driving the growth of this market are a high prevalence of diseases, rising government and nongovernment funding for vaccine development, increasing investments by companies, and increasing focus on immunization programs. With factors such as advances in immunology, genetics and vaccine technology as well as increased demand from population growth in emerging economies, the global vaccine market is expected to surpass an estimated USD 100 billion by 2025. The economies of developing countries, for example, India is growing at a tremendous speed, and it is expected to grow 10-15% within the next decade. The 10th Annual Vaccine World Summit 2002 is about advancing vaccine business, technology & innovation in developing countries to facilitate access to new vaccines and combat global pandemic threats. On 05 March 2020 Viroclinics Xplore will present the latest insights on early stage and preclinical vaccine development. Here you will read more about our conference participation.